Chronic Kidney Disease Trial, Recruiting (NCT00001979)

Chronic Kidney Disease Trial, Recruiting NCT00001979 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT00001979 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older, or children aged 10 to 17 years old
People who have a known, proven, or suspected kidney disease that involves the immune system, such as nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, or kidney inflammation linked to other immune-related conditions — or people who have an immune-related condition that could potentially affect the kidneys
The person joining the trial, or their guardian if they are a child, must be willing and able to understand the study and sign a written consent form

Who may not be able to join:

People who have other medical conditions that could make it difficult to clearly understand the results of the kidney immune disorder being studied
People who have other medical, surgical, or health conditions that the NIH facility does not have adequate resources or funding to properly support and manage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meryl A Waldman, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phone: (301) 451-6990

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00001979

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: (301) 451-6990

More information: https://clinicaltrials.gov/study/NCT00001979

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older, or children aged 10 to 17 years old
People who have a known, proven, or suspected kidney disease that involves the immune system, such as nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, or kidney inflammation linked to other immune-related conditions — or people who have an immune-related condition that could potentially affect the kidneys
The person joining the trial, or their guardian if they are a child, must be willing and able to understand the study and sign a written consent form

Who may not be able to join:

People who have other medical conditions that could make it difficult to clearly understand the results of the kidney immune disorder being studied
People who have other medical, surgical, or health conditions that the NIH facility does not have adequate resources or funding to properly support and manage

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry

ClinicalTrials.gov

Start date

25 June 1992

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Provision of biospecimens

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov